Synlogic, Inc. (NASDAQ:SYBX – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.64 and traded as low as $0.5961. Synlogic shares last traded at $0.6699, with a volume of 16,653 shares trading hands.
Synlogic Stock Performance
The business has a 50 day moving average of $0.64 and a two-hundred day moving average of $0.87. The firm has a market capitalization of $7.84 million, a price-to-earnings ratio of -2.58 and a beta of 0.52.
Hedge Funds Weigh In On Synlogic
A number of institutional investors have recently modified their holdings of SYBX. Citadel Advisors LLC acquired a new stake in Synlogic in the 3rd quarter valued at $49,000. Renaissance Technologies LLC increased its stake in Synlogic by 116.7% during the 4th quarter. Renaissance Technologies LLC now owns 85,627 shares of the biotechnology company’s stock valued at $96,000 after purchasing an additional 46,117 shares in the last quarter. Finally, DRW Securities LLC acquired a new position in Synlogic during the fourth quarter worth $27,000. 63.40% of the stock is owned by institutional investors and hedge funds.
Synlogic Company Profile
Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.
See Also
- Five stocks we like better than Synlogic
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Synlogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synlogic and related companies with MarketBeat.com's FREE daily email newsletter.
